The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Candel Therapeutics Inc’s stock clocked out at $5.01, up 4.16% from its previous closing price of $4.81. In other words, the price has increased by $4.16 from its previous closing price. On the day, 0.74 million shares were traded.
Ratios:
To gain a deeper understanding of CADL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.77 and its Current Ratio is at 2.77. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on February 20, 2025, initiated with a Buy rating and assigned the stock a target price of $25.
On February 19, 2025, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $20.
On February 07, 2025, BofA Securities started tracking the stock assigning a Buy rating and target price of $15.BofA Securities initiated its Buy rating on February 07, 2025, with a $15 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 18 ’25 when Nichols William Garrett sold 45,316 shares for $8.76 per share. The transaction valued at 396,995 led to the insider holds 52,493 shares of the business.
Barone Francesca sold 32,146 shares of CADL for $281,673 on Mar 18 ’25. The Chief Scientific Officer now owns 96,527 shares after completing the transaction at $8.76 per share. On Mar 18 ’25, another insider, Tak Paul Peter, who serves as the Chief Executive Officer of the company, sold 25,772 shares for $8.77 each. As a result, the insider received 226,023 and left with 226,140 shares of the company.
Stock Price History:
Over the past 52 weeks, CADL has reached a high of $14.60, while it has fallen to a 52-week low of $3.79. The 50-Day Moving Average of the stock is -18.83%, while the 200-Day Moving Average is calculated to be -23.02%.
Shares Statistics:
A total of 46.93M shares are outstanding, with a floating share count of 36.07M. Insiders hold about 26.80% of the company’s shares, while institutions hold 34.59% stake in the company.
